01 1Laurus Labs
01 1CANAGLIFLOZIN
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-02-28
Pay. Date : 2016-12-20
DMF Number : 31233
Submission : 2017-01-22
Status : Active
Type : II
20
Laurus Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CANAGLIFLOZIN, with a corresponding US DMF Number 31233.
Remarkably, this DMF maintains an Active status since its submission on January 22, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 28, 2017, and payment made on December 20, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
